Subscribe

Synlogic, Inc. (SYBX)

USD0.70 +0.00 (+0.00%)
US OTC Healthcare Biotechnology
Address PO Box 30 1890
Winchester, MA, US
CEO Mary Beth Dooley
IPO 2015-09-30
CIK 1527599 ISIN US87166L2097

Explore sections of this company profile

Description

Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.

Market Cap & Enterprise Value
Merger & Acquisition History
Target company Ticker Date Filing
Mirna MIRN 2017-06-21 View
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD0.70 +0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
11.8K
Beta
0.56
Float Shares
7.10M
Free Float %
60.7%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.17% -7.44% -5.98% -4.02% -64.46% -46.70% -46.22% -92.76% -98.85% -99.87% -99.87%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (14 ratings, all time) Buy
Price Targets & DCF
Current price
0.70
DCF (Unlevered) 1.18 +68.8%
DCF (Levered) 1.19 +70.0%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 50% Bullish
Rating 2024-11 Change
Strong Buy 1 0
Buy 0 0
Hold 1 -1
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
-40.45
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
  • Revenue growth Biotechnology: +1.6%
    -100.0%
  • EPS growth Biotechnology: +29.7%
    +95.8% Q1'26: +95.3% (vs Q1'25)
  • FCF margin FCF growth · Biotechnology: +16.2%
  • EBIT margin Biotechnology: +0.0%
  • ROIC Biotechnology: -16.1%
    Q1'26: +0.0% (vs Q1'25)
  • Share dilution Biotechnology: -3.4%
    +1.0% Q1'26: +0.1% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×
    0.00× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.52) × ERP
WACC = 100% × Ke + 0% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 1.18 Current price: 0.70
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2017
actual
Dec 2018
actual
Dec 2019
actual
Dec 2020
actual
Dec 2021
actual
Dec 2022
actual
Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
1 Rev. Ana.
1 EPS Ana.
Dec 2027
1 Rev. Ana.
1 EPS Ana.
Dec 2028
1 Rev. Ana.
1 EPS Ana.
Revenue
2.44M
est: 1.84M (+33.0%)
2.52M
est: 2.62M (-3.9%)
2.22M
est: 1.52M (+46.4%)
545.0K
est: 525.7K (+3.7%)
1.75M
est: 1.37M (+27.8%)
1.18M
est: 1.31M (-10.1%)
3.37M
est: 3.17M (+6.3%)
8.0K
est: 263.3K (-97.0%)
est: 4.48M (-100.0%)
22.75M
22.75M – 22.75M
+408.1% YoY
83.24M
83.24M – 83.24M
+265.9% YoY
232.99M
232.99M – 232.99M
+179.9% YoY
EBITDA
-38.01M
est: -1.84M (-1,968.9%)
-45.97M
est: -2.62M (-1,653.1%)
-48.65M
est: -1.52M (-3,102.2%)
-56.53M
est: -525.7K (-10,653.2%)
-58.12M
est: -1.37M (-4,134.6%)
-63.63M
est: -1.31M (-4,749.5%)
-55.31M
est: -1.90M (-2,807.9%)
-22.06M
est: -158.0K (-13,861.5%)
-3.53M
est: -2.69M (-31.5%)
-13.65M
-13.65M – -13.65M
-408.1% YoY
-49.95M
-49.95M – -49.95M
-265.9% YoY
-139.79M
-139.79M – -139.79M
-179.9% YoY
EBIT
-40.32M
est: -1.84M (-2,094.6%)
-48.39M
est: -2.62M (-1,745.4%)
-51.35M
est: -1.52M (-3,280.0%)
-59.17M
est: -525.7K (-11,154.6%)
-60.56M
est: -1.37M (-4,312.6%)
-66.15M
est: -1.31M (-4,941.5%)
-57.27M
est: -1.90M (-2,910.9%)
-23.35M
est: -158.0K (-14,681.1%)
-3.53M
est: -2.69M (-31.5%)
-13.65M
-13.65M – -13.65M
-408.1% YoY
-49.95M
-49.95M – -49.95M
-265.9% YoY
-139.79M
-139.79M – -139.79M
-179.9% YoY
Net Income
-40.38M
est: -821.73M (+95.1%)
-48.44M
est: -392.56M (+87.7%)
-51.37M
est: -324.74M (+84.2%)
-59.17M
est: -305.78M (+80.6%)
-60.56M
est: -212.95M (+71.6%)
-66.15M
est: -171.51M (+61.4%)
-57.28M
est: -67.37M (+15.0%)
-23.36M
est: -33.37M (+30.0%)
-1.01M
est: -5.79M (+82.6%)
-2.83M
-2.83M – -2.83M
+51.1% YoY
-15.14M
-15.14M – -15.14M
-434.8% YoY
75.60M
75.60M – 75.60M
+599.2% YoY
SGA
12.93M
est: 323.66M (-96.0%)
15.72M
est: 461.96M (-96.6%)
14.73M
est: 267.65M (-94.5%)
13.54M
est: 92.61M (-85.4%)
15.39M
est: 241.77M (-93.6%)
16.56M
est: 231.13M (-92.8%)
14.56M
est: 543.34M (-97.3%)
6.63M
est: 45.14M (-85.3%)
3.49M
est: 767.53M (-99.5%)
3.90B
3.90B – 3.90B
+408.1% YoY
14.27B
14.27B – 14.27B
+265.9% YoY
39.93B
39.93B – 39.93B
+179.9% YoY
EPS
-90.07
est: -67.38 (-33.7%)
-30.42
est: -32.19 (+5.5%)
-24.11
est: -26.63 (+9.4%)
-23.67
est: -25.07 (+5.6%)
-15.76
est: -17.46 (+9.7%)
-13.57
est: -14.06 (+3.5%)
-8.81
est: -5.47 (-61.0%)
-1.92
est: -2.71 (+29.2%)
-0.08
est: -0.47 (+83.0%)
-0.23
-0.23 – -0.23
+51.1% YoY
-1.23
-1.23 – -1.23
-434.8% YoY
6.14
6.14 – 6.14
+599.2% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-11 C+ 2/5 5/5 1/5 1/5 1/5 1/5 4/5
2026-05-08 C+ 2/5 5/5 1/5 1/5 1/5 1/5 4/5
2026-05-07 C+ 2/5 5/5 1/5 1/5 1/5 1/5 4/5
2026-05-06 C+ 2/5 5/5 1/5 1/5 1/5 1/5 4/5
2026-05-05 C+ 2/5 5/5 1/5 1/5 1/5 1/5 4/5
2026-05-04 C+ 2/5 5/5 1/5 1/5 1/5 1/5 4/5
2026-05-01 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-30 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-29 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-28 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-27 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-24 C+ 2/5 5/5 1/5 1/5 1/5 1/5 4/5
2026-04-22 C+ 2/5 5/5 1/5 1/5 1/5 1/5 4/5
2026-04-21 C+ 2/5 5/5 1/5 1/5 1/5 1/5 4/5
2026-04-17 C+ 2/5 5/5 1/5 1/5 1/5 1/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-4.46M
OE per share TTM
-0.36
Owner's Yield
-56.65%
Maintenance CapEx ratio
0.00%
Maint CapEx / Avg PPE
1,310.0%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
1
Total invested
12.00
Insider transactions (90d)
0
Beneficial owners (>5%)
45
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 Ginkgo Bioworks, Inc. 8.89M 19.99% 8.89M 8.89M CO Delaware 2019-06-21
2 FMR LLC 7.45M 15.46% 1.63M 7.45M HC Delaware 2021-05-10
3 Peter Kolchinsky 6.67M 9.90% 6.67M HC, IN United States of America 2021-10-01
4 RA Capital Healthcare Fund, L.P. 6.67M 9.90% 6.67M PN United States of America 2021-10-01
5 RA Capital Management, L.P. 6.67M 9.90% 6.67M IA, PN United States of America 2021-10-01
6 Rajeev Shah 6.67M 9.90% 6.67M HC, IN United States of America 2021-10-01
7 Wellington Group Holdings LLP 3.56M 14.00% 3.30M HC Massachusetts 2018-05-10
8 Wellington Investment Advisors Holdings LLP 3.56M 14.00% 3.30M HC Massachusetts 2018-05-10
9 Wellington Management Group LLP 3.56M 14.00% 3.30M HC Massachusetts 2018-05-10
10 Wellington Management Company LLP 3.44M 13.50% 3.30M IA Massachusetts 2018-05-10
11 Funicular Funds, LP 3.31M 36.00% 240.00 PN 2024-02-16
12 Anthony A. Florence, Jr. 2.97M 14.80% 2.97M 10.00 IN United States citizen 2015-10-14
13 David M. Mott 2.97M 14.80% 2.97M 10.00 IN United States citizen 2015-10-14
14 Forest Baskett 2.97M 14.80% 2.97M 10.00 IN United States citizen 2015-10-14
15 Harry R. Weller 2.97M 14.80% 2.97M 10.00 IN United States citizen 2015-10-14
16 Krishna S. Kolluri 2.97M 14.80% 2.97M 10.00 IN United States citizen 2015-10-14
17 M. James Barrett 2.97M 14.80% 2.97M 10.00 IN United States citizen 2015-10-14
18 NEA 14 GP, LTD 2.97M 14.80% 2.97M 10.00 CO Cayman Islands 2015-10-14
19 NEA Partners 14, L.P. 2.97M 14.80% 2.97M 10.00 PN Cayman Islands 2015-10-14
20 New Enterprise Associates 14, L.P. 2.97M 14.80% 2.97M 10.00 PN Cayman Islands 2015-10-14
21 Patrick J. Kerins 2.97M 14.80% 2.97M 10.00 IN United States citizen 2015-10-14
22 Peter J. Barris 2.97M 14.80% 2.97M 10.00 IN United States citizen 2015-10-14
23 Peter W. Sonsini 2.97M 14.80% 2.97M 10.00 IN United States citizen 2015-10-14
24 Ravi Viswanathan 2.97M 14.80% 2.97M 10.00 IN United States citizen 2015-10-14
25 Abigail P. Johnson 1.43M 6.86% 1.43M IN United States of America 2016-02-12
26 Hawkes Bay Master Investors (Cayman) L.P. 1.35M 5.30% 1.35M PN Cayman Islands 2018-04-16
27 Mr. Marc Schneidman 1.33M 5.20% 1.33M HC, IN United States 2019-02-14
28 Samuel D. Isaly 1.31M 8.08% 1.31M 10.00 IN United States 2017-09-07
29 Armistice Capital, LLC 1.29M 9.99% 1.29M IA, OO Delaware 2024-02-14
30 Steven Boyd 1.29M 9.99% 1.29M HC, IN Delaware 2024-02-14
31 Select Biotechnology Portfolio 1.15M 5.51% 1.15M IV Massachusetts 2016-02-12
32 EASTERN CAPITAL LIMITED 1.12M 5.40% 1.12M 1.12M CO CAYMAN ISLANDS 2015-10-15
33 KENNETH B. DART 1.12M 5.40% 1.12M 1.12M IN CAYMAN ISLANDS 2015-10-15
34 PORTFOLIO SERVICES LTD. 1.12M 5.40% 1.12M 1.12M CO CAYMAN ISLANDS 2015-10-15
35 Company, L.P. 850.1K 5.22% 850.1K PN Delaware 2017-09-06
36 Deerfield Mgmt III, L.P. 850.1K 5.22% 850.1K PN Delaware 2017-09-06
37 Deerfield Private Design Fund III, L.P. 850.1K 5.22% 850.1K PN Delaware 2017-09-06
38 James E. Flynn 850.1K 5.22% 850.1K IN United States 2017-09-06
39 Bradley L. Radoff 629.2K 5.40% 629.2K IN USA 2024-04-18
40 OrbiMed Advisors LLC 402.0K 4.70% 402.0K 10.00 IA Delaware 2023-10-04
41 ( 13-5315170 356.8K 1.67% 356.8K 356.8K CO Delaware 2018-02-13
42 OrbiMed Capital GP VI LLC 290.9K 3.40% 290.9K 10.00 OO Delaware 2023-10-04
43 OrbiMed Genesis GP LLC 111.1K 1.30% 111.1K 10.00 OO Delaware 2023-10-04
44 Aquilo Capital Management, LLC 0.00% IA, HC, OO California 2020-02-14
45 Marc Schneidman 0.00% HC, IN United States 2020-02-14

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
1
-24 vs prev Q
New positions
0
Closed positions
24
Increased
0
Reduced
0
Put/Call ratio
0.00
Calls held
Puts held
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 CABLE CAR CAPITAL LLC 3.31M +— (+0.0%) 3.71M -1.8M (-32.9%) 26.89% 0.000 pp 0.12% -2.244 pp USD1.76 -36.4% 8 qtrs
2 NEA MANAGEMENT COMPANY, LLC 2.92M +— (+0.0%) 3.27M -1.6M (-32.9%) 23.73% 0.000 pp 0.17% -0.101 pp USD3.75 -70.1% 10 qtrs
3 VANGUARD GROUP INC 201.1K +4.6K (+2.3%) 225.2K -106.8K (-32.2%) 1.63% +0.037 pp 0.00% +0.000 pp USD2.89 -61.2% 10 qtrs
4 CITADEL ADVISORS LLC 141.6K +112.6K (+388.1%) 158.6K +109.6K (+223.5%) 1.15% +0.914 pp 0.00% +0.000 pp USD1.23 -8.9% 9 qtrs
5 RENAISSANCE TECHNOLOGIES LLC 85.6K +46.1K (+116.7%) 95.9K +30.0K (+45.5%) 0.70% +0.374 pp 0.00% +0.000 pp USD1.64 -31.7% 9 qtrs
6 GEODE CAPITAL MANAGEMENT, LLC 71.6K +4.0K (+5.9%) 80.2K -34.1K (-29.8%) 0.58% +0.032 pp 0.00% +0.000 pp USD2.47 -54.7% 10 qtrs
7 DRW SECURITIES, LLC 24.4K +24.4K (+100.0%) 27.3K +27.3K (+100.0%) 0.20% +0.198 pp 0.00% +0.001 pp USD1.12 +0.0% 1 qtrs NEW
8 IKARIAN CAPITAL, LLC 20.0K -456.0 (-2.2%) 22.4K -12.2K (-35.2%) 0.16% -0.004 pp 0.00% -0.002 pp USD2.81 -60.1% 10 qtrs
9 BLACKROCK, INC. 19.8K +— (+0.0%) 22.1K -10.8K (-32.9%) 0.16% +0.000 pp 0.00% +0.000 pp USD1.49 -24.8% 6 qtrs
10 NORTHERN TRUST CORP 19.5K +— (+0.0%) 21.8K -10.7K (-32.9%) 0.16% +0.000 pp 0.00% +0.000 pp USD1.67 -32.9% 2 qtrs
11 JANE STREET GROUP, LLC 15.0K +15.0K (+100.0%) 16.8K +16.8K (+100.0%) 0.12% +0.122 pp 0.00% +0.000 pp USD1.12 +0.0% 1 qtrs NEW
12 XTX TOPCO LTD 14.4K +3.2K (+28.9%) 16.1K -2.8K (-14.6%) 0.12% +0.026 pp 0.00% -0.001 pp USD1.55 -27.7% 2 qtrs
13 SUSQUEHANNA INTERNATIONAL GROUP, LLP 11.6K +11.6K (+100.0%) 13.0K +13.0K (+100.0%) 0.09% +0.094 pp 0.00% +0.000 pp USD1.12 +0.0% 3 qtrs
14 STATE STREET CORP 10.2K +— (+0.0%) 11.4K -5.8K (-33.7%) 0.08% +0.000 pp 0.00% +0.000 pp USD2.81 -60.1% 10 qtrs
15 FMR LLC 5.3K +— (+0.0%) 6.0K -3.0K (-33.7%) 0.04% +0.000 pp 0.00% +0.000 pp USD2.81 -60.1% 10 qtrs
16 UBS GROUP AG 2.5K +2.5K (+100.0%) 2.8K +2.8K (+100.0%) 0.02% +0.021 pp 0.00% +0.000 pp USD1.12 +0.0% 1 qtrs NEW
17 MORGAN STANLEY 1.1K +— (+0.0%) 1.2K -600.0 (-32.9%) 0.01% +0.000 pp 0.00% +0.000 pp USD3.05 -63.3% 10 qtrs
18 FLAGSHIP HARBOR ADVISORS, LLC 1.0K +1.0K (+100.0%) 1.2K +1.2K (+100.0%) 0.01% +0.008 pp 0.00% +0.000 pp USD1.12 +0.0% 1 qtrs NEW
19 SBI SECURITIES CO., LTD. 103.00 +— (+0.0%) 115.00 -57.0 (-33.1%) 0.00% +0.000 pp 0.00% +0.000 pp USD1.23 -8.9% 5 qtrs
20 BANK OF AMERICA CORP /DE/ 66.00 +2.0 (+3.1%) 73.00 -34.0 (-31.8%) 0.00% +0.000 pp 0.00% +0.000 pp USD1.41 -20.6% 9 qtrs
21 BNP PARIBAS ARBITRAGE, SNC 24.00 +— (+0.0%) 27.00 -13.0 (-32.5%) 0.00% +0.000 pp 0.00% +0.000 pp USD1.38 -18.8% 5 qtrs
22 HILLTOP NATIONAL BANK 20.00 +— (+0.0%) 22.00 -11.0 (-33.3%) 0.00% +0.000 pp 0.00% +0.000 pp USD1.25 -10.4% 3 qtrs
23 CITIGROUP INC 1.00 +— (+0.0%) 1.00 -1.0 (-50.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD1.00 +12.0% 2 qtrs
24 DANSKE BANK A/S 1.00 +— (+0.0%) 1.00 -1.0 (-50.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD1.00 +12.0% 6 qtrs
25 JPMORGAN CHASE & CO 1.00 +— (+0.0%) 1.00 -1.0 (-50.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD2.00 -44.0% 10 qtrs
26 BARCLAYS PLC -1.0 (-100.0%) -2.0 (-100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD 2 qtrs SOLD
27 WELLS FARGO & COMPANY/MN -5.0 (-100.0%) -8.0 (-100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD 2 qtrs SOLD
28 JONES FINANCIAL COMPANIES LLLP -20.0 (-100.0%) -35.0 (-100.0%) 0.00% 0.000 pp 0.00% +0.000 pp USD 2 qtrs SOLD
Ownership breakdown by holder

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
1
Shares acquired
Shares disposed
157.00
Cash buys
Cash sales
1.00
Net activity
-157
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2025-10-29 Dooley Mary Beth Officer S-Sale D Common Stock 157 1.81 284.17 12,744 D
2025-04-26 Shea Richard P Director A-Award A Common Stock 15,000 0.00 15,506 D
2025-04-26 Flynn James P Director A-Award A Common Stock 15,000 0.00 15,000 D
2025-04-02 Dooley Mary Beth Officer S-Sale D Common Stock 144 1.20 172.80 12,901 D
2025-02-03 Dooley Mary Beth Officer S-Sale D Common Stock 2,107 1.33 2.8K 13,045 D
2024-10-29 Dooley Mary Beth Officer S-Sale D Common Stock 79 1.40 110.60 15,152 D
2024-04-02 Dooley Mary Beth Officer S-Sale D Common Stock 188 1.73 325.24 15,231
2024-04-02 Awad Antoine Officer S-Sale D Common Stock 372 1.73 643.56 33,859
2024-03-19 Flynn James P Director A-Award A Stock Option (right to buy) 4,000 1.78 7.1K 4,000
2024-03-18 Dooley Mary Beth Officer D Stock Option (right to buy) 3,612 1.85 6.7K 0
2024-02-09 Funicular Funds, LP 10% Owner D Common stock 0 0.00 3,312,219
2024-01-02 Hurter Patricia N. Director A-Award A Stock Option (right to buy) 14,678 4.47 65.6K 14,678
2024-01-02 Barrett Peter Director A-Award A Stock Option (right to buy) 24,923 4.47 111.4K 24,923
2023-11-10 JENSEN MICHAEL VANGSTED Officer A-Award A Stock Option (right to buy) 13,332 1.85 24.7K 13,332
2023-11-10 Brennan Aoife Director / Officer D-Return D Stock Option (right to buy) 12,332 128.85 1.59M 0
2023-11-10 Awad Antoine Officer A-Award A Stock Option (right to buy) 3,666 1.85 6.8K 3,666
2023-10-03 New Enterprise Associates 14, L.P. 10% Owner D Common Stock 0 0.00 2,922,773
2023-06-22 Shea Richard P Director A-Award A Stock Option (right to buy) 30,000 0.50 15.1K 30,000
2023-06-22 Mathers Edward T Director A-Award A Stock Option (right to buy) 30,000 0.50 15.1K 30,000
2023-06-22 Leschly Nick Director A-Award A Stock Option (right to buy) 30,000 0.50 15.1K 30,000
2023-06-22 Kelly-Croswell Lisa Director A-Award A Stock Option (right to buy) 30,000 0.50 15.1K 30,000
2023-06-22 Hurter Patricia N. Director A-Award A Stock Option (right to buy) 30,000 0.50 15.1K 30,000
2023-06-22 Heffernan Michael Thomas Director A-Award A Stock Option (right to buy) 30,000 0.50 15.1K 30,000
2023-06-22 Burgess Michael F. Director A-Award A Stock Option (right to buy) 30,000 0.50 15.1K 30,000
2023-06-22 Barrett Peter Director A-Award A Stock Option (right to buy) 30,000 0.50 15.1K 30,000
2023-04-03 JENSEN MICHAEL VANGSTED Officer S-Sale D Common Stock 2,553 0.58 1.5K 46,947
2023-04-03 Brennan Aoife Director / Officer S-Sale D Common Stock 19,042 0.58 11.0K 256,301
2023-04-03 Awad Antoine Officer S-Sale D Common Stock 6,438 0.58 3.7K 74,732
2023-01-03 Hurter Patricia N. Director A-Award A Stock Option (right to buy) 91,954 0.00 91,954
2023-01-03 Barrett Peter Director A-Award A Stock Option (right to buy) 156,130 0.00 156,130
2022-06-09 Shea Richard P Director A-Award A Stock Option (right to buy) 27,000 0.00 27,000
2022-06-09 Mathers Edward T Director A-Award A Stock Option (right to buy) 27,000 0.00 27,000
2022-06-09 Leschly Nick Director A-Award A Stock Option (right to buy) 27,000 0.00 27,000
2022-06-09 Kelly-Croswell Lisa Director A-Award A Stock Option (right to buy) 27,000 0.00 27,000
2022-06-09 Hurter Patricia N. Director A-Award A Stock Option (right to buy) 27,000 1.17 31.6K 27,000
2022-06-09 Heffernan Michael Thomas Director A-Award A Stock Option (right to buy) 27,000 0.00 27,000
2022-06-09 Burgess Michael F. Director A-Award A Stock Option (right to buy) 27,000 0.00 27,000
2022-06-09 Barrett Peter Director A-Award A Stock Option (right to buy) 27,000 0.00 27,000
2022-05-24 JENSEN MICHAEL VANGSTED Officer P-Purchase A Common Stock 9,500 1.12 10.6K 39,500
2022-04-04 Brennan Aoife Officer S-Sale D Common Stock 8,894 2.45 21.8K 275,343
2022-04-04 Awad Antoine Officer S-Sale D Common Stock 2,650 2.45 6.5K 81,170
2022-03-03 JENSEN MICHAEL VANGSTED Officer A-Award A Stock Option (right to buy) 230,000 0.00 230,000
2022-02-04 Brennan Aoife Director / Officer A-Award A Common Stock 106,920 0.00 284,237
2022-02-04 Awad Antoine Officer A-Award A Common Stock 40,820 0.00 83,820
2022-01-03 Barrett Peter Director A-Award A Stock Option (right to buy) 49,334 2.42 119.4K 49,334
2021-12-06 BELOFF GREGG Officer A-Award A Stock Option (right to buy) 50,000 2.34 117.0K 50,000
2021-06-10 Shea Richard P Director A-Award A Stock Option (right to buy) 15,000 3.67 55.1K 15,000
2021-06-10 Mathers Edward T Director A-Award A Stock Option (right to buy) 15,000 3.67 55.1K 15,000
2021-06-10 Leschly Nick Director A-Award A Stock Option (right to buy) 15,000 3.67 55.1K 15,000
2021-06-10 Kelly-Croswell Lisa Director A-Award A Stock Option (right to buy) 15,000 3.67 55.1K 15,000
2021-06-10 Hurter Patricia N. Director A-Award A Stock Option (right to buy) 15,000 3.67 55.1K 15,000
2021-06-10 Heffernan Michael Thomas Director A-Award A Stock Option (right to buy) 15,000 3.67 55.1K 15,000
2021-06-10 Burgess Michael F. Director A-Award A Stock Option (right to buy) 15,000 3.67 55.1K 15,000
2021-06-10 Barrett Peter Director A-Award A Stock Option (right to buy) 12,818 3.67 47.0K 12,818
2021-04-20 ORBIMED ADVISORS LLC Director A-Award A Common Stock, $0.001 par value 1,666,666 3.00 5.00M 3,696,662
2021-04-20 Khuong Chau Quang Director A-Award A Common Stock, $0.001 par value 1,666,666 3.00 5.00M 3,696,662
2021-03-10 Riese Richard J. Officer A-Award A Stock Option (right to buy) 70,000 3.50 245.0K 70,000
2021-03-10 Brennan Aoife Director / Officer A-Award A Stock Option (right to buy) 285,000 3.50 997.5K 285,000
2021-03-10 Awad Antoine Officer A-Award A Stock Option (right to buy) 70,000 3.50 245.0K 70,000
2021-02-09 Kelly-Croswell Lisa Director A-Award A Stock Option (right to buy) 30,000 4.95 148.5K 30,000
2021-01-04 Barrett Peter Director A-Award A Stock Option (right to buy) 57,498 2.20 126.5K 57,498
2020-12-08 Heffernan Michael Thomas Director A-Award A Stock Option (right to buy) 30,000 2.29 68.7K 30,000
2020-07-30 Awad Antoine Officer D Stock Option (right to buy) 55,000 8.69 478.0K 0
2020-07-24 Barrett Peter Director A-Award A Stock Option (right to buy) 1,541 2.23 3.4K 1,541
2020-06-04 Shea Richard P Director A-Award A Stock Option (right to buy) 15,000 2.22 33.3K 15,000
2020-06-04 Mathers Edward T Director A-Award A Stock Option (right to buy) 15,000 2.22 33.3K 15,000
2020-06-04 Leschly Nick Director A-Award A Stock Option (right to buy) 15,000 2.22 33.3K 15,000
2020-06-04 Khuong Chau Quang Director A-Award A Stock Option (right to buy) 15,000 2.22 33.3K 15,000
2020-06-04 Hurter Patricia N. Director A-Award A Stock Option (right to buy) 15,000 2.22 33.3K 15,000
2020-06-04 Burgess Michael F. Director A-Award A Stock Option (right to buy) 15,000 2.22 33.3K 15,000
2020-06-04 Barrett Peter Director A-Award A Stock Option (right to buy) 15,000 2.22 33.3K 15,000
2020-03-10 Riese Richard J. Officer A-Award A Common Stock 13,500 0.00 21,500
2020-03-10 Brennan Aoife Director / Officer A-Award A Stock Option (right to buy) 185,300 1.70 315.0K 185,300
2020-02-03 Burgess Michael F. Director A-Award A Stock Option (right to buy) 30,000 2.51 75.3K 30,000
2020-01-02 Barrett Peter Director A-Award A Stock Option (right to buy) 48,656 2.68 130.4K 48,656
2019-12-31 Riese Richard J. Officer A-Award A Stock Option (right to buy) 150,000 2.58 387.0K 150,000
2019-12-13 Shea Richard P Director P-Purchase A Common Stock 7,500 2.74 20.6K 7,500
2019-10-23 BELOFF GREGG Officer A-Award A Stock Option (right to buy) 50,000 2.30 115.0K 50,000
2019-10-21 BELOFF GREGG Officer 0 0.00 0
2019-09-23 Riese Richard J. Officer A-Award A Common Stock 8,000 0.00 8,000
2019-09-23 PLEVY SCOTT ERIC Officer A-Award A Common Stock 8,000 0.00 8,000
2019-09-23 Brennan Aoife Director / Officer A-Award A Common Stock 8,000 0.00 59,767
2019-09-16 Riese Richard J. Officer 0 0.00 0
2019-06-28 PLEVY SCOTT ERIC Officer A-Award A Stock Option (right to buy) 150,000 9.10 1.37M 150,000
2019-06-11 Ginkgo Bioworks, Inc. 10% Owner D Common Stock 0 0.00 6,340,771
2019-06-05 Shea Richard P Director A-Award A Stock Option (right to buy) 10,000 7.30 73.0K 10,000
2019-06-05 POWELL MICHAEL Director A-Award A Stock Option (right to buy) 10,000 7.30 73.0K 10,000
2019-06-05 Mathers Edward T Director A-Award A Stock Option (right to buy) 10,000 7.30 73.0K 10,000
2019-06-05 Leschly Nick Director A-Award A Stock Option (right to buy) 10,000 7.30 73.0K 10,000
2019-06-05 Khuong Chau Quang Director A-Award A Stock Option (right to buy) 10,000 7.30 73.0K 10,000
2019-06-05 Hurter Patricia N. Director A-Award A Stock Option (right to buy) 10,000 7.30 73.0K 10,000
2019-06-05 Barrett Peter Director A-Award A Stock Option (right to buy) 10,000 7.30 73.0K 10,000
2019-05-06 PLEVY SCOTT ERIC Officer 0 0.00 0
2019-03-05 Shegog Todd Officer A-Award A Stock Option (right to buy) 58,500 8.59 502.5K 58,500
2019-03-05 Brennan Aoife Director / Officer A-Award A Stock Option (right to buy) 185,000 8.59 1.59M 185,000
2019-02-13 Miller Paul Francis Officer S-Sale D Common Stock 5,849 9.75 57.0K 48,135
2019-02-12 Miller Paul Francis Officer S-Sale D Common Stock 3,151 9.75 30.7K 53,984
2019-02-11 Hurter Patricia N. Director 0 0.00 0
2019-01-02 Barrett Peter Director A-Award A Stock Option (right to buy) 17,380 7.62 132.4K 17,380
2018-10-31 Brennan Aoife Director / Officer A-Award A Stock Option (right to buy) 150,000 7.91 1.19M 150,000
2018-10-18 Miller Paul Francis Officer S-Sale D Common Stock 3,000 9.77 29.3K 57,135
2018-09-18 Miller Paul Francis Officer S-Sale D Common Stock 3,000 13.05 39.2K 60,135
2018-09-05 Miller Paul Francis Officer S-Sale D Common Stock 3,000 12.55 37.6K 63,135
2018-08-30 Miller Paul Francis Officer S-Sale D Common Stock 1,342 9.76 13.1K 66,135
2018-08-29 Miller Paul Francis Officer S-Sale D Common Stock 1,658 9.77 16.2K 67,477
2018-07-18 Miller Paul Francis Officer S-Sale D Common Stock 3,000 11.01 33.0K 69,135
2018-06-20 Miller Paul Francis Officer S-Sale D Common Stock 1,054 9.80 10.3K 72,135
2018-06-19 Miller Paul Francis Officer S-Sale D Common Stock 946 9.75 9.2K 74,189
2018-06-13 Shea Richard P Director A-Award A Stock Option (right to buy) 10,000 9.36 93.6K 10,000
2018-06-13 POWELL MICHAEL Director A-Award A Stock Option (right to buy) 10,000 9.36 93.6K 10,000
2018-06-13 Mathers Edward T Director A-Award A Stock Option (right to buy) 10,000 9.36 93.6K 10,000
2018-06-13 Leschly Nick Director A-Award A Stock Option (right to buy) 10,000 9.36 93.6K 10,000
2018-06-13 Khuong Chau Quang Director A-Award A Stock Option (right to buy) 10,000 9.36 93.6K 10,000
2018-06-13 Barrett Peter Director A-Award A Stock Option (right to buy) 10,000 9.36 93.6K 10,000
2018-06-05 Brennan Aoife Officer A-Award A Stock Option (right to buy) 54,000 9.55 515.7K 54,000
2018-03-14 Shegog Todd Officer A-Award A Stock Option (right to buy) 48,000 9.95 477.6K 48,000
2018-03-14 Miller Paul Francis Officer A-Award A Stock Option (right to buy) 16,000 9.95 159.2K 16,000
2018-03-14 Gutierrez-Ramos Jose-Carlos Director / Officer A-Award A Stock Option (right to buy) 120,540 9.95 1.20M 120,540
2018-03-14 Gengos Andrew Officer A-Award A Stock Option (right to buy) 10,000 9.95 99.5K 10,000
2018-03-14 Brennan Aoife Officer A-Award A Stock Option (right to buy) 56,000 9.95 557.2K 56,000
2018-01-26 Viswanathan Ravi 10% Owner A-Award A Common Stock 410,000 9.75 4.00M 4,228,940
2018-01-26 Sonsini Peter W. 10% Owner A-Award A Common Stock 410,000 9.75 4.00M 4,228,940
2018-01-26 SANDELL SCOTT D 10% Owner A-Award A Common Stock 410,000 9.75 4.00M 4,228,940
2018-01-26 POWELL MICHAEL Director A-Award A Common Stock 150,000 9.75 1.46M 574,972
2018-01-26 ORBIMED ADVISORS LLC Director A-Award A Common Stock 715,000 9.75 6.97M 2,029,996
2018-01-26 New Enterprise Associates 14, L.P. 10% Owner A-Award A Common Stock 410,000 9.75 4.00M 4,228,940
2018-01-26 MOTT DAVID M 10% Owner A-Award A Common Stock 410,000 9.75 4.00M 4,228,940
2018-01-26 Khuong Chau Quang Director A-Award A Common Stock 715,000 9.75 6.97M 2,029,996
2018-01-26 KERINS PATRICK J 10% Owner A-Award A Common Stock 410,000 9.75 4.00M 4,228,940
2018-01-26 Florence Anthony A. Jr. 10% Owner A-Award A Common Stock 410,000 9.75 4.00M 4,228,940
2018-01-26 BASKETT FOREST 10% Owner A-Award A Common Stock 410,000 9.75 4.00M 4,228,940
2018-01-26 BARRIS PETER J 10% Owner A-Award A Common Stock 410,000 9.75 4.00M 4,228,940
2018-01-26 BARRETT M JAMES 10% Owner A-Award A Common Stock 410,000 9.75 4.00M 4,228,940
2018-01-02 Barrett Peter Director A-Award A Stock Option (right to buy) 11,570 10.80 125.0K 11,570
2017-12-31 Gutierrez-Ramos Jose-Carlos Director / Officer 0 0.00 0
2017-12-29 Shea Richard P Director A-Award A Stock Option (right to buy) 17,143 9.70 166.3K 17,143
2017-12-29 POWELL MICHAEL Director A-Award A Stock Option (right to buy) 18,572 9.70 180.1K 18,572
2017-12-29 Mathers Edward T Director A-Award A Stock Option (right to buy) 18,572 9.70 180.1K 18,572
2017-12-29 Leschly Nick Director A-Award A Stock Option (right to buy) 17,143 9.70 166.3K 17,143
2017-12-29 Khuong Chau Quang Director A-Award A Stock Option (right to buy) 17,143 9.70 166.3K 17,143
2017-12-29 Barrett Peter Director A-Award A Stock Option (right to buy) 17,143 9.70 166.3K 17,143
2017-10-31 Gengos Andrew Officer A-Award A Stock Option (right to buy) 154,000 14.71 2.27M 154,000
2017-10-09 Gengos Andrew Officer 0 0.00 0
2017-08-28 Viswanathan Ravi 10% Owner A-Award A Common Stock 3,394,439 0.00 3,818,940
2017-08-28 Sonsini Peter W. 10% Owner A-Award A Common Stock 3,394,439 0.00 3,818,940
2017-08-28 Shegog Todd Officer D Stock Option (right to buy) 30,426 13.53 411.7K 0
2017-08-28 Shea Richard P Director 0 0.00 0
2017-08-28 SANDELL SCOTT D 10% Owner A-Award A Common Stock 3,394,439 0.00 3,818,940
2017-08-28 POWELL MICHAEL Director A-Award A Stock Option (right to buy) 1,428 12.07 17.2K 1,428
2017-08-28 ORBIMED ADVISORS LLC Director I Common Stock 0 0.00 1,314,996
2017-08-28 New Enterprise Associates 14, L.P. 10% Owner A-Award A Common Stock 3,394,439 0.00 3,818,940
2017-08-28 Miller Paul Francis Officer D Common Stock 0 0.00 33,459
2017-08-28 Mathers Edward T Director A-Award A Stock Option (right to buy) 1,428 12.07 17.2K 1,428
2017-08-28 MOTT DAVID M 10% Owner A-Award A Common Stock 3,394,439 0.00 3,818,940
2017-08-28 Leschly Nick Director D Common Stock 0 0.00 23,150
2017-08-28 Khuong Chau Quang Director A-Award A Stock Option (right to buy) 2,857 12.07 34.5K 2,857
2017-08-28 KERINS PATRICK J 10% Owner A-Award A Common Stock 3,394,439 0.00 3,818,940
2017-08-28 Gutierrez-Ramos Jose-Carlos Director / Officer D Common Stock 0 0.00 362,619
2017-08-28 Florence Anthony A. Jr. 10% Owner A-Award A Common Stock 3,394,439 0.00 3,818,940
2017-08-28 Brennan Aoife Officer D Common Stock 0 0.00 51,767
2017-08-28 Barrett Peter Director A-Award A Stock Option (right to buy) 2,857 12.07 34.5K 2,857
2017-08-28 BASKETT FOREST 10% Owner A-Award A Common Stock 3,394,439 0.00 3,818,940
2017-08-28 BARRIS PETER J 10% Owner A-Award A Common Stock 3,394,439 0.00 3,818,940
2017-08-28 BARRETT M JAMES 10% Owner A-Award A Common Stock 3,394,439 0.00 3,818,940
2017-08-28 Atlas Venture Fund IX, L.P. 10% Owner D Common Stock 0 0.00 2,651,963
2016-12-01 Irvin Jon Officer S-Sale A Common Stock 280 1.43 401.60 7,625
2016-11-11 Irvin Jon Officer S-Sale D Common Stock 150 1.45 217.50 7,905
2016-11-01 Irvin Jon Officer S-Sale D Common Stock 280 1.28 359.49 8,055
2016-10-11 Irvin Jon Officer S-Sale D Common Stock 150 1.83 273.75 8,335
2016-10-03 Irvin Jon Officer S-Sale D Common Stock 250 1.93 481.35 8,485
2016-06-29 Winkler Matthew Director A-Award A Stock Option (Right to Buy) 10,000 4.74 47.4K 10,000
2016-06-29 SIEGALL CLAY B Director A-Award A Stock Option (Right to Buy) 10,000 4.74 47.4K 10,000
2016-06-29 POWELL MICHAEL Director A-Award A Stock Option (Right to Buy) 10,000 4.74 47.4K 10,000
2016-06-29 Nisen Perry Director 0 0.00 0
2016-06-29 Mathers Edward T Director A-Award A Stock Option (Right to Buy) 10,000 4.74 47.4K 10,000
2016-06-29 Greenleaf Peter Director A-Award A Stock Option (Right to Buy) 10,000 4.74 47.4K 10,000
2016-06-29 Alleva Lawrence M Director A-Award A Stock Option (Right to Buy) 10,000 4.74 47.4K 10,000
2016-04-25 O'Neill Vincent Officer A-Award A Stock Option (Right to Buy) 250,000 4.42 1.11M 250,000
2016-03-11 Lammers Paul Director / Officer A-Award A Stock Option (Right to Buy) 165,000 4.36 719.4K 165,000
2016-03-11 Irvin Jon Officer A-Award A Stock Option (Right to Buy) 10,000 4.36 43.6K 10,000
2016-03-11 Greenleaf Peter Director A-Award A Stock Option (Right to Buy) 8,000 4.36 34.9K 8,000
2016-03-11 Fuhrman Alan Officer A-Award A Stock Option (Right to Buy) 60,000 4.36 261.6K 60,000
2016-03-11 DeYoung Casi Officer A-Award A Stock Option (Right to Buy) 60,000 4.36 261.6K 60,000
2016-03-01 Greenleaf Peter Director A-Award A Stock Option (Right to Buy) 12,000 4.55 54.6K 12,000
2015-10-06 Winkler Matthew Director J-Other A Common Stock 62,582 0.00 649,174
2015-10-06 Weller Harry R 10% Owner J-Other A Common Stock 31,650 0.00 2,114,375
2015-10-06 Viswanathan Ravi 10% Owner J-Other A Common Stock 257,516 0.00 1,499,166
2015-10-06 Sonsini Peter W. 10% Owner J-Other A Common Stock 31,650 0.00 2,114,375
2015-10-06 Sofinnova Venture Partners VIII, L.P. 10% Owner P-Purchase A Common Stock 857,142 7.00 6.00M 2,974,811
2015-10-06 SANDELL SCOTT D 10% Owner P-Purchase A Common Stock 857,142 7.00 6.00M 2,971,517
2015-10-06 POWELL MICHAEL Director / 10% Owner J-Other A Common Stock 289,841 0.00 2,117,669
2015-10-06 PFIZER INC 10% Owner J-Other A Common Stock 235,855 7.00 1.65M 2,489,364
2015-10-06 New Enterprise Associates 14, L.P. 10% Owner J-Other A Common Stock 257,516 0.00 1,499,166
2015-10-06 MOTT DAVID M 10% Owner P-Purchase A Common Stock 857,142 7.00 6.00M 2,971,517
2015-10-06 KOLLURI KRISHNA KITTU 10% Owner J-Other A Common Stock 257,516 0.00 1,499,166
2015-10-06 KERINS PATRICK J 10% Owner P-Purchase A Common Stock 857,142 7.00 6.00M 2,971,517
2015-10-06 Florence Anthony A. Jr. 10% Owner P-Purchase A Common Stock 857,142 7.00 6.00M 2,971,517
2015-10-06 BASKETT FOREST 10% Owner J-Other A Common Stock 257,516 0.00 1,499,166
2015-10-06 BARRIS PETER J 10% Owner J-Other A Common Stock 257,516 0.00 1,499,166
2015-10-06 BARRETT M JAMES 10% Owner J-Other A Common Stock 257,516 0.00 1,499,166

Executive team

Top executives
Shares Outstanding
11.70M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2015 Paul Lammers, M.D., M.Sc. President and Chief Executive Officer 387.6K 135.7K 1.05M 128.9K 10.6K 1.71M 61.20%
2 2015 Miguel Barbosa, Ph. D. 74.0K 84.9K 1.35M 21.7K 16.6K 1.55M 87.29%
3 2015 Alan Fuhrman 86.3K 825.8K 24.4K 25.4K 961.9K 85.85%
4 2014 Paul Lammers, M.D., M.Sc. President and Chief Executive Officer 375.8K 390.8K 11.3K 777.9K 50.24%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2025-11-12 DEF 14A
2024-11-06 DEF 14A
2023-09-01 DEF 14A
2023-08-21 PRE 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-04-30 10-K/A
2026-04-06 SC 13D/A
2026-03-12 10-K
2026-01-29 8-K/A
2026-01-23 SC 13G
2026-01-20 8-K
2025-12-16 8-K
2025-11-26 8-K
2025-11-13 SC 13G/A
2025-11-13 10-Q

Executive team

NameTitleCompensationGender
Jose-Carlos Gutierrez-Ramos Advisor 597.1K
Mary Beth Dooley Principal Executive Officer & Principal Financial Officer 335.5K female
James J. Collins Co-Founder & Member of Scientific Advisory Board
Timothy K. Lu Co-Founder & Member of Scientific Advisory Board
ESG Rating
B
BIOTECHNOLOGY
Rank: 190 out of 710
2025
E (Environmental)
70.5 / 56.3
Company / Sector avg.
S (Social)
60.6 / 62.4
Company / Sector avg.
G (Governance)
58.3 / 60.9
Company / Sector avg.
ESG Total
63.1 / 59.9
Company / Sector avg.
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits